Hearing aid maker Intricon is sold to health care focused investment firm for $241M
February 28, 2022 at 12:11 PM EST
The buyout price represents a 39% premium to Intricon's closing stock price on Feb. 25.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|